Arbutus Biopharma Corporation (ABUS)

NASDAQ: ABUS · IEX Real-Time Price · USD

2.750

0.00 (0.00%)

At close: Apr 24, 2024, 4:00 PM

2.700

-0.050 (-1.82%)

After-hours: Apr 24, 2024, 7:51 PM EDT

Arbutus Biopharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2009
Market Capitalization	495	419	365	526	301	158	212	278	134	243	338	Upgrade
Market Cap Growth	-	15.00%	-30.72%	74.57%	90.72%	-25.62%	-23.57%	106.91%	-44.67%	-28.17%	196.50%	Upgrade
Enterprise Value	371	295	220	373	181	71	88	164	16	62	226	Upgrade
PE Ratio	-5.75	-5.75	-5.25	-5.95	-3.97	-0.96	-3.16	-3.26	-0.35	-3.87	-8.70	Upgrade
PS Ratio	27.31	23.11	9.34	47.89	43.60	26.29	35.74	25.98	90.12	10.43	22.61	Upgrade
PB Ratio	4.67	3.95	2.66	3.11	2.96	2.17	1.06	1.52	0.66	0.44	3.84	Upgrade
P/FCF Ratio	-4.82	-4.82	-10.16	-7.70	-5.83	-2.21	-3.08	-4.97	-2.17	-4.14	-25.23	Upgrade
P/OCF Ratio	-4.88	-4.88	-10.31	-7.79	-5.86	-2.23	-3.13	-5.72	-2.32	-4.31	-27.22	Upgrade
EV/Sales Ratio	20.46	16.26	5.63	33.99	26.20	11.74	14.78	15.30	10.60	2.64	15.11	Upgrade
EV/EBITDA Ratio	-4.16	-4.16	-3.55	-5.21	-3.14	-0.43	-1.49	-1.54	-0.03	-0.79	-5.90	Upgrade
EV/EBIT Ratio	-4.08	-4.08	-3.47	-5.09	-3.03	-0.43	-1.44	-1.51	-0.03	-0.78	-5.82	Upgrade
EV/FCF Ratio	-3.39	-3.39	-6.13	-5.47	-3.51	-0.99	-1.27	-2.93	-0.26	-1.05	-16.86	Upgrade
Debt / Equity Ratio	0.02	0.02	0.02	0.02	0.03	0.05	-	0.07	0.06	-	-	Upgrade
Debt / EBITDA Ratio	-0.02	-0.02	-0.04	-0.04	-0.05	-0.02	-	-0.11	-0.02	-	-	Upgrade
Debt / FCF Ratio	-0.02	-0.02	-0.06	-0.04	-0.06	-0.05	-	-0.21	-0.19	-	-	Upgrade
Quick Ratio	5.68	5.68	4.51	13.92	13.06	11.76	11.22	8.67	12.37	17.25	5.67	Upgrade
Current Ratio	5.87	5.87	4.60	14.32	13.39	11.99	11.50	8.84	12.52	17.38	5.76	Upgrade
Asset Turnover	0.11	0.11	0.18	0.07	0.06	0.04	0.02	0.04	0.00	0.03	0.12	Upgrade
Interest Coverage	-157.71	-157.71	-36.67	-25.69	-14.89	-77.93	-270.42	-415.60	-	-	-	Upgrade
Return on Equity (ROE)	-57.80%	-57.80%	-46.20%	-68.70%	-89.80%	-131.40%	-30.30%	-47.80%	-96.70%	-11.00%	-39.40%	Upgrade
Return on Assets (ROA)	-43.40%	-43.40%	-32.60%	-54.20%	-64.80%	-105.60%	-26.30%	-34.10%	-75.90%	-8.40%	-30.20%	Upgrade
Return on Capital (ROIC)	-72.40%	-72.40%	-45.47%	-41.64%	-54.63%	-189.32%	-44.84%	-57.04%	-228.66%	-18.97%	-37.98%	Upgrade
Earnings Yield	-14.70%	-17.38%	-19.05%	-16.80%	-25.17%	-104.32%	-31.60%	-30.69%	-285.92%	-25.83%	-11.49%	Upgrade
FCF Yield	-17.54%	-20.73%	-9.84%	-12.99%	-17.14%	-45.29%	-32.46%	-20.11%	-46.04%	-24.16%	-3.96%	Upgrade
Buyback Yield / Dilution	-9.95%	-9.95%	-42.07%	-40.10%	-32.83%	-3.24%	-1.06%	-3.11%	-16.74%	-110.44%	-41.17%	Upgrade
Total Shareholder Return	-9.95%	-9.95%	-42.07%	-40.10%	-32.83%	-3.24%	-1.06%	-3.11%	-16.74%	-110.44%	-41.17%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).